Cargando…

264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973165/
http://dx.doi.org/10.1053/j.ajkd.2021.02.269
_version_ 1783666790283345920
collection PubMed
description
format Online
Article
Text
id pubmed-7973165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-79731652021-03-19 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy Am J Kidney Dis Article Published by Elsevier Inc. 2021-04 2021-03-19 /pmc/articles/PMC7973165/ http://dx.doi.org/10.1053/j.ajkd.2021.02.269 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title_full 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title_fullStr 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title_full_unstemmed 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title_short 264 Effective Reduction of Diabetic Nephropathy-Induced Albuminuria With SGLT2 inhibitor Monotherapy
title_sort 264 effective reduction of diabetic nephropathy-induced albuminuria with sglt2 inhibitor monotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973165/
http://dx.doi.org/10.1053/j.ajkd.2021.02.269